Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves’ Orbitopathy-Reference-Cited by-同舟云学术

Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves’ Orbitopathy

Published:2019-10-28 Issue:1 Volume:29 Page:193-202
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Shih Shyang-Rong¹²³,Liao Shu-Lang⁴⁵,Shih Chih-Wei⁶,Wei Yi-Hsuan⁴,Lu Ting-Xuan⁷,Chou Chien-Hsiang⁷,Yen Er-Yen⁷,Chang Yi-Cheng²⁸⁹,Lin Chia-Chi¹⁰,Chi Yu-Chiao¹¹¹,Yang Wei-Shiung²¹¹¹²¹³^ORCID,Tsai Feng-Chiao²⁷

Affiliation:

1. Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan

2. Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

3. Center of Anti-Aging and Health Consultation, National Taiwan University Hospital, Taipei, Taiwan

4. Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan

5. Department of Ophthalmology, National Taiwan University College of Medicine, Taipei, Taiwan

6. Department of Ophthalmology, Zhongxing Branch, Taipei City Hospital, Taipei, Taiwan

7. Department of Pharmacology, National Taiwan University College of Medicine, Taipei, Taiwan

8. Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine, Taipei, Taiwan

9. Institute of Biomedical Science, Academia Sinica, Taipei, Taiwan

10. Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan

11. Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan

12. Center for Obesity, Lifestyle, and Metabolic Surgery, National Taiwan University Hospital, Taipei, Taiwan

13. Research Center for Developmental Biology and Regenerative Medicine, National Taiwan University, Taipei, Taiwan

Funder

Ministry of Science and Technology, Taiwan

National Taiwan University Hospital

National Taiwan University

Liver Disease Prevention and Treatment Research Foundation, Taiwan

Wong-Yuan Endocrine Fund in Taiwan

National Health Research Institute,Taiwan

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2019.1672196

Reference32 articles.

1. Graves’ Disease

2. The eye and thyroid disease

3. The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

4. Graves' Orbitopathy: Imperfect Treatments for a Rare Disease

5. Pathogenesis of Graves Ophthalmopathy: Implications for Prediction, Prevention, and Treatment

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves’ orbitopathy;Journal of Endocrinological Investigation;2023-02-27

2. FGF-2 enhances fibrogenetic changes in TGF-β2 treated human conjunctival fibroblasts;Scientific Reports;2022-09-26

3. Therapeutic Effect of Gypenosides on Antioxidant Stress Injury in Orbital Fibroblasts of Graves’ Orbitopathy;Journal of Immunology Research;2022-09-15

4. Correction;Ocular Immunology and Inflammation;2019-11-25